- Previous Close
102.00 - Open
101.50 - Bid 100.05 x --
- Ask 101.50 x --
- Day's Range
100.05 - 101.50 - 52 Week Range
81.00 - 178.00 - Volume
567 - Avg. Volume
9,742 - Market Cap (intraday)
1.149B - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
10.61 - EPS (TTM)
9.43 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Parnax Lab Limited manufactures and sells pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. It provides cosmetic products; herbal; and nutraceutical products. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.
www.naxparlab.com12
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: PARNAXLAB.BO
View MorePerformance Overview: PARNAXLAB.BO
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PARNAXLAB.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PARNAXLAB.BO
View MoreValuation Measures
Market Cap
1.15B
Enterprise Value
1.88B
Trailing P/E
10.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.62
Price/Book (mrq)
1.46
Enterprise Value/Revenue
1.02
Enterprise Value/EBITDA
6.89
Financial Highlights
Profitability and Income Statement
Profit Margin
5.86%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.85B
Net Income Avi to Common (ttm)
108.4M
Diluted EPS (ttm)
9.43
Balance Sheet and Cash Flow
Total Cash (mrq)
16.76M
Total Debt/Equity (mrq)
95.12%
Levered Free Cash Flow (ttm)
--